GLP-1 drugs like semaglutide and tirzepatide show promise in treating obesity, with benefits including weight loss and ...

This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform ...

The Technology Networks team attended ASMS 2025 and spoke with Jim Gearing, who discusses the challenges that contaminant analysts face, and how Agilent are addressing these challenges by developing ...